Cargando…
The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
Autores principales: | Wolf, Jayanthi, Hansen, Ryan, Hassis, Kimberly, Lapps, William, Warmuth, Emese |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535798/ https://www.ncbi.nlm.nih.gov/pubmed/33032845 http://dx.doi.org/10.1016/j.vaccine.2020.09.057 |
Ejemplares similares
-
Exporting China’s Successes in Vaccine Preventable Hepatitis
por: Rodewald, Lance E.
Publicado: (2020) -
The export of hazardous industries in 2015
por: Castleman, Barry
Publicado: (2016) -
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease
por: Tell, Joan G., et al.
Publicado: (2020) -
Impact of a Hypothetical Infectious Disease Outbreak on US Exports and Export-Based Jobs
por: Bambery, Zoe, et al.
Publicado: (2018) -
Emerging Infectious Diseases: 10 Years Running
por: McDade, Joseph E., et al.
Publicado: (2005)